Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about certificate

05 Apr 2025 Evaluate
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Nectar Lifesciences has informed that it enclosed a copy of the Certificate received from Kfin Technologies, Registrar and Share Transfer Agent ‘RTA’) of the Company for the quarter ended on March 31, 2025.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..